Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4130-4140

  Wikstrand, Carol J ^a   McLendon, Roger E ^a   Friedman, Allan H ^a   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RECEPTOR DENSITY; TARGET CELL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BIOPSY; CELL COMPARTMENTATION; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM NEOPLASMS; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIOMA; HUMANS; MICE; MICROSCOPY, CONFOCAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030832167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G. H., Lazar, C. S., and Gill, G. N. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J. Biol. Chem., 259: 7761-7766, 1984.
2. Lax, I., Burgess, W. H., Bellot, F., Ullrich, A., Schlessinger, J., and Givol, D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol. Cell. Biol., 8: 1831-1839, 1988.
3. Schlessinger, J. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry, 27: 3119-3129, 1988.
4. Fernandez-Pol, J. A., Klos, D. J., and Hamilton, P. D. Modulation of transforming growth factor α-dependent expression of epidermal growth factor receptor gene by transforming growth factor β, triiodothyronine, and retinoic acid. J. Cell. Biochem., 41: 159-168, 1989.
5. Richert, N. D., Willingham, M. C., and Pastan, I. Epidermal growth factor receptor: characterization of a monoclonal antibody specific for the receptor of A431 cells. J. Biol. Chem., 258: 8902-8907, 1983.
6. Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., MacLeod, C. L., and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259: 7755-7760, 1984.
7. Waterfield, M. D., Mayes, E. L. V., Stroobant, P., Bennett, P. L. P., Young, S., Goodfellow, P. N., Banting, G. S., and Ozanne, B. A monoclonal antibody to the human epidermal growth factor receptor. J. Cell. Biochem., 20: 149-161, 1982.
8. Takahashi, H., Herlyn, D., Atkinson, B., Powe, J., Rodeck, U., Alavi, A., Bruce, D. A., and Koprowski, H. Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res., 47: 3847-3850, 1987.
9. Carlsson, J., Gedda, L., Grönvik, C., Hartman, T., Lindström, A., Lindström, P., Lundqvist, H., Lövavist, A., Malmqvist, J., Olsson, P., Essand, M., Pontén, J., Sjöberg, S., and Westermark, B. Strategy for boron neutron capture therapy against tumor cells with overexpression of the epidermal growth factor receptor. Int. J. Radiat. Oncol. Biol. Phys., 30: 105-115, 1994.
10. Fan, Z., Masui, H., Altas, I., and Mendelsohn, J. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 53: 4322-4328, 1994.
11. 2 fragment against high- and low-EGFR-expressing carcinomas in nude mice. Int. J. Cancer, 62: 643-650, 1995.
12. Bender, H., Emrich, J. G., Eshelman, J., Chu, M. A., Steplewski, Z., Biersack, H-J., and Brady, L. W. Enhancement of monoclonal antibody efficacy: the effect of external beam radiation. Hybridoma, 14: 129-134, 1995.
13. Brady, L. W., Miyamoto, C., Woo, D. V., Rackover, M., Emrich, J., Bender, H., Dadparvar, S., Steplewski, Z., Koprowski, H., Black, P., Lazzaro, B., Nair, S., McCormack, I., Nievis, J., Morrabito, M., and Eshelman, J. Malignant astrocytomas treated with iodine-125-labeled monoclonal antibody 425 against epidermal growth factor receptor: a Phase II trial. Int. J. Radiat. Oncol. Biol. Phys., 22: 225-230, 1992.
14. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin Cancer Res., 1: 859-864, 1995.
15. Lorimer, I. A. J., Keppler-Hafkemeyer, A., Beers, R. A., Bigner, D. D., and Pastan, I. Recombinant immunotoxins specific for mutant epidermal growth factor receptor: targeting with a single chain Fv isolated by phage display. Proc. Natl. Acad. Sci. USA, 93: 14815-14820, 1996.
16. Damjanov, I., Mildner, B., and Knowles, B. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab. Invest., 55: 588-570, 1986.
17. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309-4313, 1992.
18. Garcia de Palazzo, I., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 55: 3217-3220, 1993.
19. Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., and Bigner, D. D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA, 87: 4207-4211, 1990.
20. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, L., Humphrey, P. A., Kurpad, S. K., McLendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., Traweek, T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
21. Batra, S. K., Castelino-Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A., Friedman, H. S., and Bigner, D. D. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ., 6: 1251-1259, 1995.
22. Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P., and James, C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 9: 2313-2320, 1994.
23. Hills, D., Rowlinson-Busza, G., and Gulllick, W. J. Specific targeting of a mutant, activated EGF receptor found in glioblastoma using a monoclonal antibody. Int. J. Cancer, 63: 537-543, 1995.
24. Reist, C. J., Archer, G. E., Kurpad, S. N., Wikstrand, C. J., Vaidyanathan, G., Willingham, M. C., Moscatello, D. K., Wong, A. J., Bigner, D. D., and Zalutsky, M. R. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res., 55: 4375-4382, 1995.
25. Nishikawa, R., Ji, X-D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H-J. S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731, 1994.
26. Wikstrand, C. J., McLendon, R. E., Bullard, D. E., Fredman, P., Svennerholm, L., and Bigner, D. D. Production and characterization of two human glioma xenograft localizing monoclonal antibodies (mAbs). Cancer Res., 46: 5933-5940, 1986.
27. Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., and Bigner, D. D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res., 50: 8017-8022, 1990.
28. McPherson, G. A. A practical computer-based approach to the analysis of radioligand experiments. Comput. Methods Programs Biomed., 17: 107-114, 1983.
29. Wikstrand, C. J., Stanley, S. D., Humphrey, P. A., Pegram, C. N., Archer, G. E., Kurpad, S., Shibuya, M., and Bigner, D. D. Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. J. Neuroimmunol., 46: 165-174, 1993.
30. McQuaid, S., McConnell, R., McMahon, J., and Herron, B. Microwave antigen retrieval for immunocytochemistry on formalin-fixed, paraffin-embedded postmortem CNS tissue. J. Pathol., 176: 207-216, 1995.
31. Willingham, M. C. Fluorescence labeling of surface antigens of attached or suspended tissue culture cells. In: L. C. Javois (ed.), Methods in Molecular Biology, 34: Immunocytochemical Methods and Protocols, pp. 123-130. Totowa, NJ: Humana Press Inc., 1994.
32. Willingham, M. C. Fluorescence labeling of intracellular antigens of attached or suspended tissue culture cells. In: L. C. Javois (ed.), Methods in Molecular Biology, 34: Immunocytochemical Methods and Protocols, pp. 131-142. Totowa, NJ: Humana Press Inc., 1994.
33. Willingham, M. C., and Pastan, I. An Atlas of Immunofluorescence in Cultured Cells, p. 186. Orlando, FL: Academic Press, Inc., 1985.
34. Snedecor, G. W., and Cochran, W. G. Statistical Methods, 7th ed., pp. 135-148, Ames, IO: The Iowa State University Press, 1980.
35. Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A. J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995.
36. Schechter, B., Arnon, R., and Wilchek, M. Cytotoxicity of streptavidin-blocked biotin-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody. Cancer Res., 52: 4448-4452, 1992.
37. Suarez-Quian, C. A., and Byers, S. W. The distribution of epidermal growth factor receptor as a function of cell density, cell-cell adhesion, and calcium in human (A431) cells. Tissue Cell, 25: 1-17, 1993.
38. Herbst, J. J., Opresko, L. K., Walsh, B. J., Lauffenburger, D. A., and Wiley, H. S. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J. Biol. Chem., 269: 12865-12873, 1994.
39. St-Pierre, P. R., and Petersen, N. O. Average density and size of microclusters of epidermal growth factor receptors on A431 cells. Biochemistry, 31: 2459-2463, 1992.
40. Ekstrand, A. J., Liu, L., He, J., Hamid, M. L., Longo, N., Collins, V. P., and James, C. D. Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor. Oncogene, 10: 1455-1460, 1995.
41. Moscatello, D. K., Montgomery, R. B., Sundareshan, P., McDanel, H., Wong, M. Y., and Wong, A. J. Transformation and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene, 13: 85-96, 1996.
42. Goldenthal, K. L., Hedman, K., Chen, J. W., August, J. T., and Willingham, M. C. Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J. Histochem. Cytochem., 33: 813-820, 1985.
43. Malorni, W., Mewschini, S., and Arancia, G. Cytoskeleton-dependent surface blebbing induced by the polar solvent N-methylformamide. Exp. Mol. Pathol., 57: 85-104, 1992.
44. Huang, J-J. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X-D., Huang, C-M., Gill, G. N., Wiley, H. S., and Cavenee, W. K. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem., 272: 2927-2935, 1997.